Skip to Main Content

Paper Details

Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.
Diagn Pathol
6
2015
EMA, HSP90, MUC1, Pan-CK, TGF-, TGF- and CA125, benign effusions, malignant effusion, malignant effusions, patients, tumor, tumor cells
Author NameAffiliation
Qing-Rong ChenNational Institutes of Health
Qing-Rong ChenPresent affiliation: Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health
Qing-Rong ChenNational Institutes of Health
Qing-Rong ChenPresent affiliation: Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health
Javed KhanNational Institutes of Health
Javed KhanNational Institutes of Health
Stephen M HewittNational Cancer Institute, National Institutes of Health
Stephen M HewittNational Cancer Institute, National Institutes of Health
  • 1 - 8

Datasets

Release 1.2